SVR · NZX

Savor (SVR)

Consumer / HospitalityCovered: HY21 - FY2610 published briefings

Savor is an NZX-listed consumer / hospitality company with HY21 - FY26 of published result briefings.

Sections

Snapshot

Latest metrics

FY26, released 26 May 2026

← Swipe to view more

SVR latest metrics
Metric	Value	Change
Revenue	$55.2m	↓ -2.6%
EBITDA	$8m	↑ +10.3%
NPAT	$1.3m	↑ +208.3%
Operating cash flow	$6.9m	↓ -3.2%
OCF / EBITDA %	85.8%	↓ -11.9pp
Net debt	$6.3m	↓ -12.2%
Net debt / EBITDA	0.79xOutside range low net debt / ebitda. 0.79x; 5-period range 1x to 4.03x. Net debt / EBITDA: 0.79x, below normal range; 5-period mean 2.07x, range 1.00x-4.03x.	↓ -20.2%
ROE %	6.9%Outside range high roe. 6.9%; 4-period range -35.1% to 3.6%. ROE: 6.9%, above normal range; 4-period mean -13.0%, range -35.1%-3.6%.	↑ +13.9pp
PBT	$1.8m	↑ +228.6%
FCF pre-lease	$4.6m	↓ -20.1%

Source: latest published briefing (FY26, released 26 May 2026). Change compares against the prior equivalent period: FY25, released 22 May 2025.

Valuation

A compact read on what the market price implies next to the latest filing data. The numbers are a starting point for comparison, not a recommendation.

Prices as at close, 15 June 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$11.9m

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

9.15x

Recent market cap compared with trailing earnings.

EPS

0.02

Recent filing-derived earnings per share.

PEG

Not available

Not available for this company right now.

EV/EBITDA

2.28x

Enterprise value compared with recent EBITDA.

P/FCF

2.57x

Market cap compared with recent free cash flow.

P/B

0.64x

Market value compared with latest reported equity.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

0.0%

Trailing dividends compared with the latest close.

Total return

Not available

Available once dividend and adjustment data are verified.

Price history

Daily closes use the full available width, with hover and touch readouts against real observations. Expand opens the chart at reading size.

Share price

Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.

Loading chart...

Price vs earnings

Indexed lines compare direction from the first positive comparable filing point. The axis is an index, not dollars or cents.

Loading chart...

Chat

Ask about SVR

Ask follow-up questions about Savor's latest result and company history.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about SVR

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Longitudinal view

Performance over time

The latest period is shown first.

← Swipe to view more

SVR metric history
Metric	FY2612 MONTHS26 May 2026	FY2512 MONTHS22 May 2025	FY2412 MONTHS22 May 2024	HY246 MONTHS28 November 2023	FY2312 MONTHS25 May 2023	HY236 MONTHS23 November 2022	FY2212 MONTHS27 May 2022	HY226 MONTHS18 November 2021	FY2112 MONTHS28 May 2021	HY216 MONTHS27 November 2020	Trend
Revenue	$55.2m	$56.6m	$61.9m	$29.1m	$52.4m	$20.7m	$30.6m	$17.2m	$16.1m	$9.9m	Chart
Revenue growth %	-2.6%	-8.4%	18.1%	40.4%	180.2%Unprecedented high revenue growth. 180.2%; 5-period range -57.8% to 89.5%. Revenue growth: 180.2%, unprecedented high; 5-period mean 7.8%, range -57.8%-89.5%.	20.7%	89.5%	73.3%Outside range high revenue growth. 73.3%; 3-period range -45% to 40.4%. Revenue growth: 73.3%, above normal range; 3-period mean 5.4%, range -45.0%-40.4%.	-57.8%Outside range low revenue growth. -57.8%; 5-period range -8.4% to 180.2%. Revenue growth: -57.8%, below normal range; 5-period mean 55.4%, range -8.4%-180.2%.	-45.0%Outside range low revenue growth. -45%; 3-period range 20.7% to 73.3%. Revenue growth: -45.0%, below normal range; 3-period mean 44.8%, range 20.7%-73.3%.	Chart FY23 Revenue growth %: Unprecedented high revenue growth. 180.2%; 5-period range -57.8% to 89.5%. Revenue growth: 180.2%, unprecedented high; 5-period mean 7.8%, range -57.8%-89.5%.
EBITDA	$8m	$7.3m	$8.8m	$3.1m	$5.2m	$1.4m	$3m	$2.1m	$1.8m	$0.69m	Chart
EBITDA margin %	14.5%Outside range high ebitda margin. 14.5%; 5-period range 9.8% to 14.2%. EBITDA margin: 14.5%, above normal range; 5-period mean 11.5%, range 9.8%-14.2%.	12.8%	14.2%	10.7%	10.0%	6.8%Outside range low ebitda margin. 6.8%; 3-period range 6.9% to 12.3%. EBITDA margin: 6.8%, below normal range; 3-period mean 10.0%, range 6.9%-12.3%.	9.8%Outside range low ebitda margin. 9.8%; 5-period range 10% to 14.5%. EBITDA margin: 9.8%, below normal range; 5-period mean 12.4%, range 10.0%-14.5%.	12.3%Outside range high ebitda margin. 12.3%; 3-period range 6.8% to 10.7%. EBITDA margin: 12.3%, above normal range; 3-period mean 8.1%, range 6.8%-10.7%.	11.4%	6.9%	Chart FY26 EBITDA margin %: Outside range high ebitda margin. 14.5%; 5-period range 9.8% to 14.2%. EBITDA margin: 14.5%, above normal range; 5-period mean 11.5%, range 9.8%-14.2%.
PBT	$1.8m	-$1.4m	-$2.9m	-$0.4m	-$2.3m	-$2.1m	-$5m	-$0.8m	-$3.1m	-$0.4m	Chart
NPAT	$1.3m	-$1.2m	$0.7m	-$0.4m	-$2.3m	-$2.1m	-$5m	-$0.8m	-$6.6m	-$0.4m	Chart
Operating cash flow	$6.9m	$7.1m	$6.4m	$2.5m	$6.1m	$1.6m	$3m	$1.1m	$0.01m	-$0.14m	Chart
OCF / EBITDA %	85.8%	97.7%	73.0%	81.8%	116.2%Outside range high ocf / ebitda cash conversion. 116.2%; 5-period range 0.7% to 98.6%. OCF / EBITDA cash conversion: 116.2%, above normal range; 5-period mean 71.2%, range 0.7%-98.6%.	117.3%Outside range high ocf / ebitda cash conversion. 117.3%; 3-period range -20.8% to 81.8%. OCF / EBITDA cash conversion: 117.3%, above normal range; 3-period mean 38.2%, range -20.8%-81.8%.	98.6%	53.5%	0.7%Unprecedented low ocf / ebitda cash conversion. 0.7%; 5-period range 73% to 116.2%. OCF / EBITDA cash conversion: 0.7%, unprecedented low; 5-period mean 94.3%, range 73.0%-116.2%.	-20.8%	Chart FY23 OCF / EBITDA %: Outside range high ocf / ebitda cash conversion. 116.2%; 5-period range 0.7% to 98.6%. OCF / EBITDA cash conversion: 116.2%, above normal range; 5-period mean 71.2%, range 0.7%-98.6%.
FCF pre-lease	$4.6m	$5.8m	$5.9m	$2.2m	$1.8m	-$0.73m	$1m	-$0.03m	-$1.3m	-$0.56m	Chart
DPS	—	-9.0c	-8.0c	-11.0c	-13.0c	-16.0c	-18.0c	—	—	16.0c	Chart
ROE %	6.9%Outside range high roe. 6.9%; 4-period range -35.1% to 3.6%. ROE: 6.9%, above normal range; 4-period mean -13.0%, range -35.1%-3.6%.	-7.0%	3.6%	-2.5%Outside range high roe. -2.5%; 3-period range -14.9% to -2.6%. ROE: -2.5%, above normal range; 3-period mean -7.2%, range -14.9%--2.6%.	-13.5%	-14.9%Outside range low roe. -14.9%; 3-period range -4% to -2.5%. ROE: -14.9%, below normal range; 3-period mean -3.0%, range -4.0%--2.5%.	-35.1%Unprecedented low roe. -35.1%; 4-period range -13.5% to 6.9%. ROE: -35.1%, unprecedented low; 4-period mean -2.5%, range -13.5%-6.9%.	-4.0%	-51.9%	-2.6%	Chart HY24 ROE %: Outside range high roe. -2.5%; 3-period range -14.9% to -2.6%. ROE: -2.5%, above normal range; 3-period mean -7.2%, range -14.9%--2.6%. FY26 ROE %: Outside range high roe. 6.9%; 4-period range -35.1% to 3.6%. ROE: 6.9%, above normal range; 4-period mean -13.0%, range -35.1%-3.6%.
Net debt	$6.3m	$7.2m	$9.1m	$13.7m	$11.9m	$13.8m	$12.1m	$11.5m	$3.6m	$5.2m	Chart
Net debt / EBITDA	0.79xOutside range low net debt / ebitda. 0.79x; 5-period range 1x to 4.03x. Net debt / EBITDA: 0.79x, below normal range; 5-period mean 2.07x, range 1.00x-4.03x.	0.99x	1.03x	4.41xOutside range low net debt / ebitda. 4.4x; 3-period range 5.45x to 9.8x. Net debt / EBITDA: 4.40x, below normal range; 3-period mean 7.60x, range 5.45x-9.80x.	2.27x	9.84xOutside range high net debt / ebitda. 9.8x; 3-period range 4.4x to 7.55x. Net debt / EBITDA: 9.80x, above normal range; 3-period mean 5.80x, range 4.40x-7.55x.	4.03xUnprecedented high net debt / ebitda. 4.03x; 5-period range 0.79x to 2.3x. Net debt / EBITDA: 4.03x, unprecedented high; 5-period mean 1.42x, range 0.79x-2.30x.	5.45x	1.97x	7.55x	Chart HY24 Net debt / EBITDA: Outside range low net debt / ebitda. 4.4x; 3-period range 5.45x to 9.8x. Net debt / EBITDA: 4.40x, below normal range; 3-period mean 7.60x, range 5.45x-9.80x. FY26 Net debt / EBITDA: Outside range low net debt / ebitda. 0.79x; 5-period range 1x to 4.03x. Net debt / EBITDA: 0.79x, below normal range; 5-period mean 2.07x, range 1.00x-4.03x.
Debtor days	1	1	1	—	3	—	3	-1	5Unprecedented high debtor days. 5d; 5-period range 1d to 3d. Debtor days: 4.7 days, unprecedented high; 5-period mean 1.5 days, range 0.5 days-3.2 days.	4	Chart
Inventory days	6	6	5Outside range low inventory days. 5d; 5-period range 6d to 10d. Inventory days: 5.3 days, below normal range; 5-period mean 7.3 days, range 5.6 days-10.4 days.	6Outside range low inventory days. 6d; 3-period range 6d to 28d. Inventory days: 5.6 days, below normal range; 3-period mean 13.9 days, range 5.9 days-28.1 days.	7	6	7	8	10Unprecedented high inventory days. 10d; 5-period range 5d to 7d. Inventory days: 10.4 days, unprecedented high; 5-period mean 6.2 days, range 5.3 days-7.4 days.	28Outside range high inventory days. 28d; 3-period range 6d to 8d. Inventory days: 28.1 days, above normal range; 3-period mean 6.4 days, range 5.6 days-7.8 days.	Chart HY24 Inventory days: Outside range low inventory days. 6d; 3-period range 6d to 28d. Inventory days: 5.6 days, below normal range; 3-period mean 13.9 days, range 5.9 days-28.1 days. FY24 Inventory days: Outside range low inventory days. 5d; 5-period range 6d to 10d. Inventory days: 5.3 days, below normal range; 5-period mean 7.3 days, range 5.6 days-10.4 days.
Total assets	$49.6m	$51.6m	$53.8m	$56.7m	$56.4m	$54.9m	$55m	$59.6m	$36.4m	$42.1m	Chart

Reference: annolyse.ai/companies/svr

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Filing-only history charts

These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.

Revenue

Reported revenue across covered periods.

Loading chart...

Revenue growth

Like-period revenue growth where comparable.

Loading chart...

EBITDA-equivalent

Company-specific earnings measure where disclosed.

Loading chart...

EBITDA margin

EBITDA-equivalent margin where revenue and earnings are source-backed.

Loading chart...

NPAT

Statutory profit after tax.

Loading chart...

Operating cash flow

Cash generated from operations.

Loading chart...

Full chartable metric set

Additional verified filing metrics for this company. Each point links back to a published briefing period in the source data contract.

OCF / EBITDA

Cash conversion against earnings.

Loading chart...

FCF pre-lease

Operating cash flow less capex before leases.

Loading chart...

ROE

Return on equity.

Loading chart...

Net debt

Borrowings less cash; negative values indicate net cash.

Loading chart...

Net debt / EBITDA

Leverage ratio, suppressed where earnings are not meaningful.

Loading chart...

DPS

Dividend per share declared for the period.

Loading chart...

Debtor days

Receivables days where the working-capital inputs are source-backed.

Loading chart...

Inventory days

Inventory days where the working-capital inputs are source-backed.

Loading chart...

Operating working-capital movement

Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.

Loading chart...

The setup & the reality

FY25 → FY26 Follow-through

The latest result is checked against what the prior briefing said to watch.

Historical setup

What FY25 said to watch

From PBT loss narrowed 49.5% while NPAT swung to a loss on tax normalisation

No forward targets, FY26 guidance or forward-work disclosures are provided in this release, so the result cannot be benchmarked against management's own goals. The shape of the year is, however, distinctive: HY25 revenue was up over 40% on a depressed HY24 base, yet full-year revenue fell 8.4%, which implies H2 revenue of roughly $27.6m against an unusually strong H2 FY24. EBITDA was second-half weighted at the group level (H1 contributed only 43.2% of full-year EBITDA), so second-half profitability held up better than second-half revenue.

The gap that matters is the second-half revenue decline against last year's stronger comparable. The release attributes this to "reduced [activity per] head" but does not quantify volume, mix or pricing components, leaving the underlying demand trajectory into FY26 unclear.

Open questions

Open questions from FY25

What drove the second-half revenue decline against H2 FY24, and is the lower per-head spend a structural mix shift or a cyclical demand effect?
Why did the effective tax rate fall from 122.8% to 16.1%, and what is the expected normalised rate now that prior-year tax credits appear to have unwound?
How should investors read the 174.7% capex step-up to $1.3m – is this catch-up maintenance, new venue development, or the start of a sustained higher reinvestment level?
Why was no final dividend declared (payment date "Not Applicable") given the move to net cash, and what is the framework for resuming distributions?
Will the lower below-EBITDA cost base (D&A and finance costs roughly $3.0m lower year-on-year) persist, or does it reflect one-off items that won't repeat?

This briefing cannot assess the underlying volume, pricing and venue-level economics behind the second-half revenue decline because the release does not disclose them.

Briefing archive

Every published Annolyse briefing for this company appears here in reverse chronological order.

FY26 · Released 26 May 2026

Savor swung to $1.8m PBT with EBITDA margin at 14.5%

Operating margin moved above its 9.8%-14.2% five-year range as revenue softened and capex rose 69%, with PBT the cleaner read on the result.

Read briefing

FY25 · Released 22 May 2025

PBT loss narrowed 49.5% while NPAT swung to a loss on tax normalisation

Revenue fell 8.4% and EBITDA dropped 17.2%, yet operating cash flow rose 10.9% as a smaller tax benefit drove NPAT into the red.

Read briefing

FY24 · Released 22 May 2024

NPAT flipped positive on 122.7% tax rate while PBT loss widened 22.5%

EBITDA rose 68.1% on 18.1% revenue growth, but the headline profit reflects an unprecedented tax benefit rather than improvement at the pre-tax line.

Read briefing

HY24 · Released 28 November 2023

EBITDA up 130% on 40.4% revenue growth, leverage halved to 4.4x

Operating leverage drove margin expansion and deleveraging, but the group remained loss-making and HY23 was only 26% of FY23 EBITDA.

Read briefing

FY23 · Released 25 May 2023

Revenue up 180.2% drove turnaround, but $92.6m cash balance drained to zero

An unprecedented revenue rebound and a working-capital release shrank losses 93.9%, but equity fell 82.8% and the company carries new debt.

Read briefing

HY23 · Released 23 November 2022

Leverage hit 9.8x EBITDA as margins compressed on a 20.7% revenue lift

Revenue rose 20.7% but EBITDA fell 33.6%, cash turned net negative and gearing moved well above the historical range as venue capex doubled.

Read briefing

FY22 · Released 27 May 2022

Revenue up 89.5% on acquisition, but leverage hit an unprecedented 4.0x

Hipgroup lifted topline but EBITDA margin slipped to 9.8% and net debt/EBITDA reached 4.03x, while reported NPAT improvement reflects last year's

Read briefing

HY22 · Released 18 November 2021

Acquisition lifted revenue 73.3% and tripled EBITDA, but loss widened 81.4%

The Hipgroup hospitality acquisition rebased Savor's top line and EBITDA above historical ranges, yet finance costs deepened the loss and lifted

Read briefing

FY21 · Released 28 May 2021

Cash conversion collapsed to 0.7% as brewery exit drove FCF to -NZ$1.3m

Continuing-operations PBT improved 23.6% but operating cash fell 99.5% and FCF pre-lease turned negative despite a NZ$3.1m working-capital release.

Read briefing

HY21 · Released 27 November 2020

Revenue down 45%; $8m working-capital release flatters cash

An issuer transition and prior-period acquisition leave the HY20 comparison non-comparable, while the working-capital release reflects contraction

Read briefing

Get notified when SVR publishes

Get the next Savor result briefing and five-year history updates by email.

Savor (SVR)

Latest metrics

Valuation

Price and market cap

Profitability multiples

Income and fund shape

Price history

Share price

Price vs earnings

Ask about SVR

Ask about SVR

Sign in to chat

Performance over time

Filing-only history charts

Revenue

Revenue growth

EBITDA-equivalent

EBITDA margin

NPAT

Operating cash flow

Full chartable metric set

OCF / EBITDA

FCF pre-lease

ROE

Net debt

Net debt / EBITDA

DPS

Debtor days

Inventory days

Operating working-capital movement

FY25 → FY26 Follow-through

What FY25 said to watch

Open questions from FY25

Briefing archive

Savor swung to $1.8m PBT with EBITDA margin at 14.5%

PBT loss narrowed 49.5% while NPAT swung to a loss on tax normalisation

NPAT flipped positive on 122.7% tax rate while PBT loss widened 22.5%

EBITDA up 130% on 40.4% revenue growth, leverage halved to 4.4x

Revenue up 180.2% drove turnaround, but $92.6m cash balance drained to zero

Leverage hit 9.8x EBITDA as margins compressed on a 20.7% revenue lift

Revenue up 89.5% on acquisition, but leverage hit an unprecedented 4.0x

Acquisition lifted revenue 73.3% and tripled EBITDA, but loss widened 81.4%

Cash conversion collapsed to 0.7% as brewery exit drove FCF to -NZ$1.3m

Revenue down 45%; $8m working-capital release flatters cash

Compare this company

Get notified when SVR publishes

Savor (SVR)

Latest metrics

Valuation

Price and market cap

Profitability multiples

Income and fund shape

Price history

Share price

Price vs earnings

Ask about SVR

Ask about SVR

Sign in to chat

Performance over time

Filing-only history charts

Revenue

Revenue growth

EBITDA-equivalent

EBITDA margin

NPAT

Operating cash flow

Full chartable metric set

OCF / EBITDA

FCF pre-lease

ROE

Net debt

Net debt / EBITDA

DPS

Debtor days

Inventory days

Operating working-capital movement

FY25 → FY26 Follow-through

What FY25 said to watch

Open questions from FY25

Briefing archive